KUALA LUMPUR: Affin Research is maintaining its “Add” call on KPJ Healthcare Bhd with an unchanged target price of RM6.82.
“Risk to our recommendation would be prolong gestation period on its new hospitals and any futher hiccups/payment on its lawsuit,” it said.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!